| Company Name: |
ATK CHEMICAL COMPANY LIMITED
|
| Tel: |
+undefined-21-51877795 |
| Email: |
ivan@atkchemical.com |
| Products Intro: |
Product Name:IRL 2500
CAS:169545-27-1
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G
|
| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:IRL-2500;N-3-[1,1'-Biphenyl]-4-yl-N-(3,5-diMethylbenzoyl)-N-Methyl-D-alanyl-L-tryptophan
CAS:169545-27-1
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
IRL-2500 manufacturers
- IRL 2500
-
- $58.00
-
2026-05-11
- CAS:169545-27-1
- Purity: 99.36%
- Supply Ability: 10g
|
| | IRL-2500 Basic information |
| Product Name: | IRL-2500 | | Synonyms: | IRL-2500;N-3-[1,1'-BIPHENYL]-4-YL-N-(3,5-DIMETHYLBENZOYL)-N-METHYL-D-ALANYL-L-TRYPTOPHAN;L-Tryptophan, 3-[1,1'-biphenyl]-4-yl-N-(3,5-dimethylbenzoyl)-N-methyl-D-alanyl-;((R)-3-([1,1'-Biphenyl]-4-yl)-2-(N,3,5-trimethylbenzamido)propanoyl)-L-tryptophan;IRL 2500, 10 mM in DMSO | | CAS: | 169545-27-1 | | MF: | C36H35N3O4 | | MW: | 573.68 | | EINECS: | | | Product Categories: | Endothelin receptor | | Mol File: | 169545-27-1.mol |  |
| | IRL-2500 Chemical Properties |
| Boiling point | 893.7±65.0 °C(Predicted) | | density | 1.246±0.06 g/cm3(Predicted) | | storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C | | solubility | Soluble to 100 mM in 1eq. NaOH | | form | Powder | | pka | 3.34±0.10(Predicted) | | color | White to light yellow |
| | IRL-2500 Usage And Synthesis |
| Uses | IRL 2500 is a potent endothelin ETB selective antagonist. | | Biological Activity | Potent endothelin receptor antagonist; shows some selectivity for ET B receptors (IC 50 values are 1.3 and 94 nM for ET B and ET A receptors respectively). Inhibits ET B receptor-mediated blood pressure increase and renal vascular resistance in rats in vivo . | | in vivo | IRL 2500 (intravenous injection;10 mg/kg) inhibits the initial transient decrease in mean arterial pressure (MAP) induced by the ETB-selective agonist IRL 1620 in rats, IRL 2500 also attenuates the IRL 1620-mediated increase in renal vascular resistance (RVR) in the anesthetized rat[1].
IRL 2500 (intravenous injection;10 mg/kg) pre-reatment significantly reduces the initial vasodepressor response to endothelin-1 (ET-1) and IRL 1620, however, it is not alters the secondary and sustained pressor response to these agonists[2]. | | IC 50 | ETB: 1.3 nM (IC50); ETA: 94 nM (IC50) | | storage | Desiccate at RT |
| | IRL-2500 Preparation Products And Raw materials |
|